Literature DB >> 28457964

Multiple pre- and post-analytical lean approaches to the improvement of the laboratory turnaround time in a large core laboratory.

Amy H Lou1, Manal O Elnenaei2, Irene Sadek2, Shauna Thompson3, Bryan D Crocker3, Bassam A Nassar2.   

Abstract

BACKGROUND: Core laboratory (CL), as a new business model, facilitates consolidation and integration of laboratory services to enhance efficiency and reduce costs. This study evaluates the impact of total laboratory automation system (TLA), electric track vehicle (ETV) system and auto-verification (AV) of results on overall turnaround time (TAT) (phlebotomy to reporting TAT: PR-TAT) within a CL setting.
METHODS: Mean, median and percentage of outlier (OP) for PR-TAT were compared for pre- and post-CL eras using five representative tests based on different request priorities. Comparison studies were also carried out on the intra-laboratory TAT (in-lab to reporting TAT: IR-TAT) and the delivery TAT (phlebotomy to in-lab TAT: PI-TAT) to reflect the efficiency of the TLA (both before and after introducing result AV) and ETV systems respectively.
RESULTS: Median PR-TATs for the urgent samples were reduced on average by 16% across all representative analytes. Median PR-TATs for the routine samples were curtailed by 51%, 50%, 49%, 34% and 22% for urea, potassium, thyroid stimulating hormone (TSH), complete blood count (CBC) and prothrombin time (PT) respectively. The shorter PR-TAT was attributed to a significant reduction of IR-TAT through the TLA. However, the median PI-TAT was delayed when the ETV was used. Application of various AV rules shortened the median IR-TATs for potassium and urea. However, the OP of PR-TAT for the STAT requests exceeding 60min were all higher than those from the pre-CL era.
CONCLUSIONS: TLA and auto-verification rules help to efficiently manage substantial volumes of urgent and routine samples. However, the ETV application as it stands shows a negative impact on the PR-TAT.
Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Auto-verification rules; Electric track vehicle; Laboratory efficiency; Total laboratory automation

Mesh:

Year:  2017        PMID: 28457964     DOI: 10.1016/j.clinbiochem.2017.04.019

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Weekly laboratory turn-around time identifies poor performance masked by aggregated reporting.

Authors:  Lindi-Marie Coetzee; Naseem Cassim; Deborah K Glencross
Journal:  Afr J Lab Med       Date:  2020-12-21

2.  Externalities of Lean Implementation in Medical Laboratories. Process Optimization vs. Adaptation and Flexibility for the Future.

Authors:  Simona Andreea Apostu; Valentina Vasile; Cristina Veres
Journal:  Int J Environ Res Public Health       Date:  2021-11-23       Impact factor: 3.390

3.  Use of Middleware Data to Dissect and Optimize Hematology Autoverification.

Authors:  Rachel D Starks; Anna E Merrill; Scott R Davis; Dena R Voss; Pamela J Goldsmith; Bonnie S Brown; Jeff Kulhavy; Matthew D Krasowski
Journal:  J Pathol Inform       Date:  2021-04-07

4.  Timely delivery of laboratory efficiency information, Part II: Assessing the impact of a turn-around time dashboard at a high-volume laboratory.

Authors:  Naseem Cassim; Lindi M Coetzee; Manfred E E Tepper; Louella Perelson; Deborah K Glencross
Journal:  Afr J Lab Med       Date:  2020-04-23

5.  Using laboratory data to categorise CD4 laboratory turn-around-time performance across a national programme.

Authors:  Lindi-Marie Coetzee; Naseem Cassim; Deborah K Glencross
Journal:  Afr J Lab Med       Date:  2018-06-28

6.  Implementation of total laboratory automation at a tertiary care hospital in Saudi Arabia: effect on turnaround time and cost efficiency.

Authors:  Tracy Louise Ellison; Maha Alharbi; Morad Alkaf; Shamad Elimam; Mariam Alfaries; Randa Al Nounou; Rasheed Nasr; Tarek Owaidah
Journal:  Ann Saudi Med       Date:  2018 Sep-Oct       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.